Skip to content

Anti-beta-2-Glycoprotein I IgM

by Neomedica Doo Niš Serbia EUDAMED

Ref N259A24B2M EMDN W0102100503

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-86060147195434 Basic UDI-DIDate29 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
N259A24B2M
Primary DI / UDI-DI
86060147195434
Basic UDI-DI
B-86060147195434
EMDN Code
W0102100503 Anti-b2-glycoprotein i antibodies
Device Class
Class IVD General
Market of Registration
Northern Ireland

Manufacturer details

EUDAMED SRN
RS-MF-000021305
Authorised representative
Wellkang Ltd XI-AR-000001836

Other devices from Neomedica Doo Niš

See all devices from Neomedica Doo Niš →

Properties & raw data

Show properties, registry sources and raw records
  • Professional Testing
Other properties (9)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 33aaccd8-aa4c-4d9d-887a-8c826e671bbd 61 fields · synced 24 Oct 2026